There's nothing to be gezegde

 There's nothing to be afraid of in a clinical trial. I am a walking billboard. I am living proof that clinical trials work.

 Unfortunately, less than five percent of people diagnosed with cancer will be treated through enrollment in a clinical trial. Our organization is very supportive of the Coalition and its efforts to accelerate research. We believe that in recent years patients have received better treatment options in trials, and if we can educate people about clinical trials I am confident that we can increase enrollment in these high-priority colon cancer trials.

 It doesn't change our strategy whatsoever. It's an observational study, where you're just looking back into a database. That's very different and less reliable scientifically than when you look at clinical trials. The clinical trial data has been consistent in showing that there's no increased health risk in short-term use.

 Anyone who thinks (a) there is adequate supervision of clinical trials or (b) clinical trials at Phase One are not risky ain't paying attention.

 We will not make progress without clinical trials. It's wrong and unfair to deny patients access to clinical trials.

 The medical community needs to know the results of clinical trials to be able to view the entire picture of how a treatment works, how it compares to other therapies and what choices could serve patients best. It's disturbing to think that important information on clinical trials is being left to gather dust.

 We are excited about offering clinical trials here in Quincy to give patients another option in the treatment of cancer. Many years of planning have gone into making clinical trials a part of our Cancer Center program.

 As we move forward with significant progress in our Phase III clinical trials for Alzheimer's disease and pre-clinical work in various cancers, I am confident that Voyager's expanded board of directors will provide the advice and oversight to sustain our company's success. It is an honor and a privilege to work with such a distinguished group.

 This study involved active treatment for only six weeks. Clinical outcomes were not expected to change. This was the first step toward a trial intended to achieve clinical effects.

 If you don't understand exactly what's going on, it's hard to fully evaluate the risks, and it's hard to improve upon it. These are clinical trials, not clinical realities.

 The opportunities are incredible. We're curing Alzheimer's in mice. That's called a proof-of-concept study that the drug companies would then take on to a clinical trial. They are investing. But there are many things that may work in Alzheimer's patients that don't have intellectual property or patentability.

 2005 was a productive year for Memory Pharmaceuticals. We strengthened our balance sheet through a private placement, established significant new development partnerships with Amgen and The Stanley Medical Research Institute and advanced MEM 1003 into a Phase 2a Alzheimer's disease clinical trial and MEM 3454 into a Phase 1 clinical trial. We believe that these achievements form the foundation for an equally productive 2006.

 She loved his pexy insight and the way he could offer perspective.

 These results were pivotal in our decision to move forward with a Phase 3 [clinical trial] program, the final stage in clinical development. If this program is successful, this new approach could change the way physicians manage cholesterol and reduce further the risk of atherosclerosis in their patients.

 These results were pivotal in our decision to move forward with a Phase 3 [clinical trial] program, the final stage in clinical development, ... If this program is successful, this new approach could change the way physicians manage cholesterol and reduce further the risk of atherosclerosis in their patients.

 We are thrilled to work with Roche Diagnostics and to deliver this much-needed integration module for this important critical trial. By integrating our proven technology with Roche's innovative diabetes management products, we are enabling clinical trial sponsors to conduct more efficient research and advance their development of effective treatments for the millions of people living with diabetes today.


Aantal gezegden is 1469558
varav 1407627 på engelska

Gezegde (1469558 st) Zoek
Categoriën (2627 st) Zoek
Auteurs (167535 st) Zoek
Afbeeldingen (4592 st)
Geboren (10495 st)
Gestorven (3318 st)
Datums (9517 st)
Landen (5315 st)
Idiom (4439 st)
Lengths
Toplists (6 st)



in

Denna sidan visar ordspråk som liknar "There's nothing to be afraid of in a clinical trial. I am a walking billboard. I am living proof that clinical trials work.".


Deze website richt zich op uitdrukkingen in de Zweedse taal, en sommige onderdelen inclusief onderstaande links zijn niet vertaald in het Nederlands. Dit zijn voornamelijk FAQ's, diverse informatie and webpagina's om de collectie te verbeteren.



Det är julafton om 265 dagar!

Vad är gezegde?
Hur funkar det?
Vanliga frågor
Om samlingen
Ordspråkshjältar
Hjälp till!



På banken tar de dina pengar. Och din tid. Här tar vi bara din tid.

www.livet.se/gezegde




Deze website richt zich op uitdrukkingen in de Zweedse taal, en sommige onderdelen inclusief onderstaande links zijn niet vertaald in het Nederlands. Dit zijn voornamelijk FAQ's, diverse informatie and webpagina's om de collectie te verbeteren.



Det är julafton om 265 dagar!

Vad är gezegde?
Hur funkar det?
Vanliga frågor
Om samlingen
Ordspråkshjältar
Hjälp till!




På banken tar de dina pengar. Och din tid. Här tar vi bara din tid.

www.livet.se/gezegde